Decitabine (Accord Healthcare Inc.)


Welcome to the PulseAid listing for the Decitabine drug offered from Accord Healthcare Inc.. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Accord Healthcare Inc.
NON-PROPRIETARY NAME: decitabine
SUBSTANCE NAME: DECITABINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-03-08
END MARKETING DATE: 0000-00-00


Decitabine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDecitabine from Accord Healthcare Inc.
LABELER NAME: Accord Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/20mL)
START MARKETING DATE: 2017-03-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16729-224_4a4fdf61-c80b-06db-e054-00144ff88e88
PRODUCT NDC: 16729-224
APPLICATION NUMBER: ANDA203475

Other DECITABINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Decitabine
Dr.Reddy’s Laboratories IncDecitabine
Dr.Reddy’s Laboratories LimitedDecitabine
Eisai Inc.Dacogen
Otsuka America Pharmaceutical, Inc.Dacogen
Sandoz IncDecitabine